- $496.59m
- $339.07m
- $41.29m
- 57
- 23
- 63
- 45
REG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Total Voting Rights
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Filing of Form 10-Q
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - First Quarter Financial Results
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Exercise of options and PDMR dealing
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Signing of Strategic Platform License
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Director/PDMR Shareholding
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Notice of First Quarter 2023 Financial Results
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Director/PDMR Shareholding
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Appointment of Chief Financial Officer
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Grant of Options and PDMR Dealing
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Filing of Form 10-K
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - 2022 Full Year Results
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Establishment of New Scientific Advisory Board
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Preliminary Unaudited Q4 &FY 2022 Revenue Results
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Director/PDMR Shareholding
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Notice of Results
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Exercise of options and PDMR dealing
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Signing of Strategic Platform License
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Signing of Strategic Platform License
Announcement